Quantcast
 
Read Larry Connors' blogShort Term Trading Strategies


 

Richmont Sciences Selected as Pure Bioscience's Sales and Marketing Team

Tue. October 20, 2009; Posted: 11:24 PM
Stocks RSS
Oct 21, 2009 (Close-Up Media via COMTEX) -- PURE | Quote | Chart | News | PowerRating -- Pure Bioscience said that it has expanded its business strategy through an alliance with the Dallas-based sales and marketing team Richmont Sciences, which will begin actively selling Pure's new antibacterial, antiviral and antifungal hard surface disinfectant and its active ingredient.

Pure's patented antimicrobial SDC (silver dihydrogen citrate) is the first new generation disinfectant to be registered with the U.S. Environmental Protection Agency in more than 30 years, the Company noted in a release.

The Company said that unlike traditional alcohol- or bleach-based surface disinfectants, SDC-based disinfectants continue killing bacteria for up to 24 hours. Bacterial kill times for SDC are as quick as 30 seconds, compared with up to ten minutes for other products.

Pure's CEO, Michael L. Krall, said today's announcement represents a new, more aggressive approach to selling by Pure Bioscience. "Public concern is rising sharply over the serious health dangers of illnesses such as Swine Flu. We have extraordinary new technology and products that can protect lives. It is time to take a more direct role in getting our products into businesses, homes, schools, hospitals and anywhere they can help fight against illness caused by viruses and bacteria."

"We are truly excited to be working with Pure to bring these extraordinary products to the places where they are so desperately needed to protect against illness," said John Rochon, Richmont's chairman. "This is more than just marketing. It is about saving lives by introducing a whole new category of long-lasting, broad spectrum germicides."

"Our alliance with Richmont brings a group of world class marketers directly onto Pure's team," said Krall. "With Richmont quarterbacking our go-to-market strategy, we will have a more direct link to our markets and customers. This strengthens our business model at a time when the marketplace is demanding the kind of antibacterial solutions we offer."

((Comments on this story may be sent to health@closeupmedia.com))

For full details for PURE click here.

    


More News:   Market Updates | Stock Alerts | All Trading News | Stock Index

Email
Print
Archives
Feedback
Email Article Link
Close X
Recipients email address
Your name
Your email
Add a note (optional)




Stocks RSS





Most Popular News
  UPCOMING EVENTS
Learn new strategies, how to trade in this market, and the stocks you should be focusing on each day. Join us for our free 20 minute tele-seminars during the week.
* Attendance is strictly limited and are filled on a first-come, first-served basis.
PREMIER SPONSORED LINKS
TRADE CENTER
 
The TradingMarkets Directory
RELATED SITES
Nothing but forex
Please call 1-213-955-5858 ext. 1

About TradingMarkets | Contact | Advertise | Careers | Link to Us | Site Map | Help | Terms & Conditions | Privacy Policy | Return Policy | Testimonials | Feedback

Disclaimer:

The Connors Group, Inc. ("Company") is not an investment advisory service, nor a registered investment advisor or broker-dealer and does not purport to tell or suggest which securities or currencies customers should buy or sell for themselves. The analysts and employees or affiliates of Company may hold positions in the stocks, currencies or industries discussed here. You understand and acknowledge that there is a very high degree of risk involved in trading securities and/or currencies. The Company, the authors, the publisher, and all affiliates of Company assume no responsibility or liability for your trading and investment results. Factual statements on the Company's website, or in its publications, are made as of the date stated and are subject to change without notice.

It should not be assumed that the methods, techniques, or indicators presented in these products will be profitable or that they will not result in losses. Past results of any individual trader or trading system published by Company are not indicative of future returns by that trader or system, and are not indicative of future returns which be realized by you. In addition, the indicators, strategies, columns, articles and all other features of Company's products (collectively, the "Information") are provided for informational and educational purposes only and should not be construed as investment advice. Examples presented on Company's website are for educational purposes only. Such set-ups are not solicitations of any order to buy or sell. Accordingly, you should not rely solely on the Information in making any investment. Rather, you should use the Information only as a starting point for doing additional independent research in order to allow you to form your own opinion regarding investments. You should always check with your licensed financial advisor and tax advisor to determine the suitability of any investment.

HYPOTHETICAL OR SIMULATED PERFORMANCE RESULTS HAVE CERTAIN INHERENT LIMITATIONS. UNLIKE AN ACTUAL PERFORMANCE RECORD, SIMULATED RESULTS DO NOT REPRESENT ACTUAL TRADING AND MAY NOT BE IMPACTED BY BROKERAGE AND OTHER SLIPPAGE FEES. ALSO, SINCE THE TRADES HAVE NOT ACTUALLY BEEN EXECUTED, THE RESULTS MAY HAVE UNDER- OR OVER-COMPENSATED FOR THE IMPACT, IF ANY, OF CERTAIN MARKET FACTORS, SUCH AS LACK OF LIQUIDITY. SIMULATED TRADING PROGRAMS IN GENERAL ARE ALSO SUBJECT TO THE FACT THAT THEY ARE DESIGNED WITH THE BENEFIT OF HINDSIGHT. NO REPRESENTATION IS BEING MADE THAT ANY ACCOUNT WILL OR IS LIKELY TO ACHIEVE PROFITS OR LOSSES SIMILAR TO THOSE SHOWN.

The Connors Group, Inc.
10 Exchange Place, Suite 1800
Jersey City, NJ 07302

© Copyright 2009 The Connors Group, Inc.


All analyst commentary provided on TradingMarkets.com is provided for educational purposes only. The analysts and employees or affiliates of TradingMarkets.com may hold positions in the stocks or industries discussed here. This information is NOT a recommendation or solicitation to buy or sell any securities. Your use of this and all information contained on TradingMarkets.com is governed by the Terms and Conditions of Use. Please click the link to view those terms. Follow this link to read our Editorial Policy.

© 2009 The Connors Group, Inc.